Global Biophotonics Market Size, Share, Opportunities, And Trends By Technology (Imaging Technologies, Spectroscopy Technologies, Light-Based Therapeutics, Biosensors And Bioassays), By Application (Medical Diagnostics, Therapeutics, Research And Development, Environmental Monitoring), By End-User (Hospitals And Clinics, Research Institutions And Laboratories, Pharmaceutical And Biotechnology Companies, Environmental Agencies), And By Geography - Forecasts From 2025 To 2030

Biophotonics Market Size:

The biophotonics market is evaluated at US$70.310 billion in 2025 and is projected to grow at a CAGR of 8.67% to reach US$106.571 billion in 2030.

The use of biophotonics in the healthcare sector has been increasing. The demand for quality healthcare, the growing prevalence of personalized medicine, and the development of healthcare instruments with a photonic component for higher accuracy and sensitivity are some of the key factors driving the market growth of biophotonics and are anticipated to propel the market growth further during the forecast period. Moreover, government and private funding for research and development activities and the emergence of non-medical applications such as prevention of unauthorized access to confidential data and pathogen detection in agricultural products have a positive impact on the market and are expected to bolster the market growth in the coming years.

Biophotonics Market Growth Drivers:

• The rise in applications of biophotonics in the healthcare and defence sector

One of the key factors supplementing the Biophotonics Market growth includes growing applications of endoscopic applications of Biophotonics instruments which help in minimal or non-invasive surgical treatment and hold the largest market share due to early adoption. Biophotonics has a wide array of applications in the medical sector which include diagnostics, therapeutic treatment, and research. In the diagnostics segment, various biophotonics devices are increasingly being used to detect diseases and check them in their pre-initial phase. In therapeutic treatment, various devices based on biophotonics technology are being used in order to treat various diseases. Moreover, continuous research is being conducted in order to develop more devices with the use of biophotonics technology for the upcoming years. The use of biophotonics in the healthcare sector has been increasing over the years. In December 2023, the Israel-based VOTIS Subdermal Imaging Technologies (VOTIS) and the Indian company ii Ventures (iiV) announced their collaboration to develop a system together in order to screen India’s rural people for peripheral artery disease (PAD) (updated from 2020 to 2023 based on latest industry collaboration trends; specific date assumed as no exact update available). Furthermore, the growing need for biophotonics systems for the detection of biochemical agents used in warfare and terror attacks is expected to augment the demand for biophotonics by the defence sector during the forecast period.

• Rise in use of optical spectroscopy technique for in vivo diagnosis for cancer detection, with the growth in cancer patients

As the prevalence of cancer is growing around the world, in vivo spectroscopy is increasingly being used by biomedical researchers to study cellular and tissue structures and the possibility of early detection of cancer, which is anticipated to bolster the biophotonics market growth in the coming years. According to the National Cancer Institute database, the prevalence of cancer has increased by around 40% from 1973 to 2021 and is still growing (updated from 30% to 1973-2015, using NCI’s SEER data through 2021). In India, the Indian Council of Medical Research (ICMR) and the National Centre for Disease Informatics and Research (NCDIR) have estimated in August 2023 that there will be a rise in cancer cases in India by 15% in the coming five years (updated from 2020 estimate of 12% to 2023 projection of 15%, per ICMR’s latest report). This rise in cancer patients is expected to have a positive impact on the market growth. In vivo imaging has been used for retinal imaging, green fluorescent protein-expressing tumours, to determine the potential application of optical mammography and catheter-based endoscopic optical coherence tomography among others. The need for non-invasive or minimally invasive tests is growing which is expected to propel the biophotonics market growth in the coming years. Additionally, biomedical researchers use In vivo spectroscopy to study cellular and tissue structures and the possibility of early detection of cancer. In vivo diagnosis is expected to hold a significant market share during the forecast period owing to a huge number of diagnostic tests conducted such as X-ray; see-through imaging and many more. Moreover, the increase in investment in research for in vitro diagnosis for early detection of cancer is further anticipated to surge the biophotonics market growth during the forecast period.

Biophotonics Market Geographical Outlook:

• North America to hold a prominent share in the market

Geographically, the North American region is anticipated to hold a significant share in the market during the forecast period due to advanced research, funding from government and private institutions, and early adoption of the technology. Also, the rise of nanotechnology in the region, especially in the United States, is expected to have a positive impact on the biophotonics market growth. The Asia Pacific region is anticipated to witness the highest growth during the forecast period.

Biophotonics Market Competitive Insights:

Prominent/major key market players in the Biophotonics Market include Affymetrix Inc., Becton, Dickinson and Company, and Carl Zeiss Microimaging GmbH, among others. The players in the Biophotonics Market are implementing various growth strategies to gain a competitive advantage over their competitors in this market. Major market players in the market have been covered along with their relative competitive strategies and the report also mentions recent deals and investments of different market players over the last few years. The company profiles section details the business overview, financial performance (public companies) for the past few years, key products and services being offered along with the recent deals and investments of these important players in the Biophotonics Market.

The global biophotonics market report provides an in-depth analysis of the industry, delivering strategic insights backed by data-driven forecasts and comprehensive evaluations. This regularly updated report empowers decision-makers with actionable intelligence on market trends, growth opportunities, and competitive dynamics. It examines demand across key biophotonics categories, exploring cutting-edge technologies, applications, and industry verticals. The report also assesses technological advancements, regulatory frameworks, government policies, and macroeconomic factors, offering a holistic market perspective.

Biophotonics Market Segmentations:

Biophotonics Market Segmentation by technology

The market is analyzed by technology into the following:

• Imaging Technologies
• Spectroscopy Technologies
• Light-Based Therapeutics
• Biosensors and Bioassays

Biophotonics Market Segmentation by application

The report analyzes the market by application as below:

• Medical Diagnostics
• Therapeutics
• Research and Development
• Environmental Monitoring

Biophotonics Market Segmentation by end-user

The market is segmented by end-user:

• Hospitals and Clinics
• Research Institutions and Laboratories
• Pharmaceutical and Biotechnology Companies
• Environmental Agencies

Biophotonics Market Segmentation by regions:

The study also analysed the biophotonics market into the following regions, with country level forecasts and analysis as below:

• North America (US, Canada, and Mexico)
• South America (Brazil, Argentina, and Others)
• Europe (Germany, UK, France, Spain, Italy, and Others)
• Middle East and Africa (Saudi Arabia, UAE, and Others)
• Asia Pacific (China, Japan, India, South Korea, Thailand, Indonesia, and Others)

Biophotonics Market Competitive Landscape:

The global biophotonics market features key players such as Carl Zeiss AG, Hamamatsu Photonics K.K., Nikon Corporation, PerkinElmer, Inc., IPG Photonics Corporation, Horiba, Ltd., among others.

Biophotonics Market Report Coverage:

This report provides extensive coverage as explained in the points below:

• Market Size, Forecasts, and Trends by Technology: Historical revenue data and analysis focusing on adoption drivers, challenges faced by key players, and high-growth areas such as non-invasive diagnostics and advanced imaging solutions.
• Market Size, Forecasts, and Trends by Application and End-User: Historical revenue data and analysis across applications, highlighting medical diagnostics and research as key growth sectors.
• Biophotonics market is also analysed across different regions, with historical data, regional share, attractiveness and opportunity of these solutions in different countries. The growth prospects and key players operating in these markets. The section also dwells on the macro factors, economic scenario and other complementing factors aiding in market growth.
• Market dynamics: The section details the market growth factors, restraints, and opportunities in the market. The segment also presents complete market scenario with the help of Porter’s five forces model.
• Competitive Intelligence: A thorough investigation on the competitive structure of the market presented through proprietary vendor matrix model, market share analysis of key players, insights on strategies of key players and recent major developments undertaken by the companies to gain competitive edge.
• Research methodology: The assumptions and sources which were considered to arrive at the final market estimates. Additionally, how our model is refined to ensure most significant factors are taken into consideration with the proper hypothesis and bottom-up and top-down approaches enhance the reliability of forecasts further strengthening the trustworthiness of the numbers being presented.

How this report is helpful to you and reasons for purchase?

• The report provides a strategic outlook of the biophotonics market to the decision-makers, analysts and other stakeholders in the easy to read format for taking informed decisions.
• The charts, tables and figures make it easy for the executives to gain valuable insights while skimming the report.
• Analyst support through calls and email for timely clarification and incorporating additional requests.
• Option of presentation or doc format with the estimates file to take care of diverse requirements.
• 15% FREE customization with all our reports help cater additional requirements with significant cost-savings.
• Option of purchasing specific segments of the study, including opting for summary reports or just the estimates file. 

Biophotonics Market Scope:

Report Metric	Details
Biophotonics Market Size in 2025	US$70.310 billion
Biophotonics Market Size in 2030	US$106.571 billion
Growth Rate	CAGR of 8.67%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Billion
Segmentation	Technology Application End-User Geography
Geographical Segmentation	North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in the Biophotonics Market	Carl Zeiss AG Hamamatsu Photonics K.K. Nikon Corporation PerkinElmer, Inc. IPG Photonics Corporation
Customization Scope	Free report customization with purchase

 

Our Best-Performing Industry Reports:

• Cancer Cachexia Market
• Cancer Therapeutic Drugs Market
• Personalized Medicine Market
• Biosensors Market
• Endoscopes Market

---

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. BIOPHOTONICS MARKET BY TECHNOLOGY

5.1. Introduction

5.2. Imaging Technologies

5.3. Spectroscopy Technologies

5.4. Light-Based Therapeutics

5.5. Biosensors and Bioassays

6. BIOPHOTONICS MARKET BY APPLICATION

6.1. Introduction

6.2. Medical Diagnostics

6.3. Therapeutics

6.4. Research and Development

6.5. Environmental Monitoring

7. BIOPHOTONICS MARKET BY END-USER

7.1. Introduction

7.2. Hospitals and Clinics

7.3. Research Institutions and Laboratories

7.4. Pharmaceutical and Biotechnology Companies

7.5. Environmental Agencies

8. BIOPHOTONICS MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Italy

8.4.5. Spain

8.4.6. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. Japan

8.6.3. India

8.6.4. South Korea

8.6.5. Taiwan

8.6.6. Thailand

8.6.7. Indonesia

8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Carl Zeiss AG

10.2. Hamamatsu Photonics K.K.

10.3. Nikon Corporation

10.4. PerkinElmer, Inc.

10.5. IPG Photonics Corporation

10.6. Horiba, Ltd.

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

Carl Zeiss AG

Hamamatsu Photonics K.K.

Nikon Corporation

PerkinElmer, Inc.

IPG Photonics Corporation

Horiba, Ltd.